• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » inVentiv Health names Jeffrey Wilks president of advertising

inVentiv Health names Jeffrey Wilks president of advertising

November 13, 2014
CenterWatch Staff

inVentiv Health, a life science knowledge and services company for the new healthcare environment, has appointed of Jeffrey Wilks as president of its advertising businesses. Wilks will report to Mike Griffith, executive vice president, inVentiv Health and president, inVentiv Commercial.

Wilks will work to ensure that all of inVentiv’s customers are able to tap the company’s digital expertise across its line of advertising agencies—including social media capabilities and creative –to help them more effectively reach their target audiences. inVentiv’s advertising businesses include healthcare-focused agencies GSW, Palio+Ignite, Navicor, JSA, inVentiv Health Communications (Europe) and Addison Whitney.

Wilks joins the company at a seminal moment when advertising is undergoing a reinvention both in and out of the healthcare sector.

“The digital transformation of advertising and marketing within the technology and e-commerce categories has enormous potential and applicability in healthcare,” said Wilks. “The mobile health marketplace is racing to match the swift proliferation of on-the-go health apps, while traditional advertising is rapidly shifting to a content marketing approach. I look forward to advancing our capabilities, and the data-driven insights that guide them, across inVentiv’s agencies to help our clients achieve their goals.”

Wilks brings to inVentiv more than three decades of experience managing brand and integrated marketing businesses for leading global technology companies such as IBM and Dell Computers, as well as Delta Airlines, MasterCard and Johnson & Johnson. He joins inVentiv from eBay Enterprise, where he was head of client services in the Marketing Solutions Group. There he led a team that tailored technology-based marketing solutions for top brands such as Toys“R”Us, Wells Fargo and Sony. Before eBay, he was senior vice president, brand development at Gannett, working to re-position USA Today for the digital age.

Complementing advertising, inVentiv’s Commercial capabilities include sales teams and sales training, strategic and tactical market access services, non-personal promotion, public relations, medical communications, adherence services, and full management of commercialization teams. When combined with inVentiv’s CRO capabilities, the organization facilitates product development and commercialization intended to accelerate client performance.

Upcoming Events

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

  • VaccinewithNeedle-360x240.png

    2021 Vaccine Industry Will Continue to be Dominated by COVID-19 Trials, Experts Say

  • Dominate-360x240.png

    COVID-19, Oncology, CNS and Infectious Disease Trials Will Dominate in 2021, Survey Predicts

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing